# AXSM (Axsome Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Axsome Therapeutics, Inc. reported $865.3M in revenue and a net loss of $157.3M for the trailing twelve months ended September 30, 2026 (up 51.9% year over year), with a 93.2% gross margin and a -17.5% operating margin.

- Canonical: https://convexityos.com/fundamentals/AXSM
- Markdown: https://convexityos.com/fundamentals/AXSM.md
- SEC CIK: 0001579428
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:11 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001579428&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $865.3M | +51.9% YoY |
| Operating Income | TTM | -$151.0M | -17.5% margin |
| Net Income | TTM | -$157.3M | -18.2% net margin |
| Diluted EPS | TTM | -$3.00 | Split-adjusted |
| Free Cash Flow | TTM | -$82.61M | -9.5% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $313.9M | Total debt: $224.2M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $638.5M | $385.7M | $270.6M | $0 | -- | -- | -- | -- | -- | -- |
| Cost of Revenue | $47.48M | $33.30M | $26.07M | $5.20M | -- | -- | -- | -- | -- | -- |
| **Gross Profit** | $591.0M | $352.4M | $244.5M | -$5.20M | -- | -- | -- | -- | -- | -- |
| Research & Development | $183.3M | $187.1M | $97.94M | $57.95M | $58.06M | $70.24M | $53.65M | $23.50M | $19.96M | $21.20M |
| Selling, General & Admin | $570.6M | $411.4M | $323.1M | $159.3M | $66.65M | $28.90M | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | -- | $124.7M | $99.14M | $67.25M | $32.85M | $27.16M | $27.54M |
| **Operating Income** | -$166.8M | -$280.6M | -$231.8M | -$179.8M | -$124.7M | -$99.14M | -$67.25M | -$32.85M | -$27.16M | -$27.54M |
| **EBITDA** | -$159.9M | -$273.6M | -$225.0M | -$175.4M | -$124.6M | -$99.12M | -$67.21M | -$32.80M | -$27.12M | -$27.52M |
| Interest Income | $9.37M | $15.01M | $13.58M | $2.32M | -- | -- | -- | -- | -- | -- |
| Interest Expense | -$15.93M | -$21.58M | -$20.03M | -$9.66M | -- | -- | -- | -- | -- | -- |
| Income Before Tax | -$183.7M | -$287.1M | -$238.3M | -$187.1M | -$130.4M | -- | -- | -- | -- | -- |
| Income Tax Expense | -$530K | $85K | $960K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$183.2M | -$287.2M | -$239.2M | -$187.1M | -$130.4M | -$102.9M | -$68.35M | -$30.97M | -$28.94M | -$27.20M |
| Basic EPS | -$3.68 | -$5.99 | -$5.27 | -$4.60 | -$3.47 | -$2.77 | -$2.01 | -$1.15 | -$1.27 | -$1.42 |
| **Diluted EPS** | -$3.68 | -$5.99 | -$5.27 | -$4.60 | -$3.47 | -$2.77 | -$2.01 | -$1.15 | -$1.27 | -$1.42 |
| Basic Shares Outstanding | 49.7M | 47.9M | 45.4M | 40.7M | 37.6M | 37.2M | 34.0M | 26.9M | 22.8M | 19.2M |
| Diluted Shares Outstanding | 49.7M | 47.9M | 45.4M | 40.7M | 37.6M | 37.2M | 34.0M | 26.9M | 22.8M | 19.2M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $259.7M | $218.4M | $191.2M | $196.0M | $171.0M | $150.0M | $121.5M | $118.8M |
| Cost of Revenue | $17.80M | $13.56M | $14.72M | $12.33M | $11.91M | $13.45M | $9.79M | $10.51M |
| **Gross Profit** | $241.9M | $204.8M | $176.5M | $183.7M | $159.1M | $136.6M | $111.7M | $108.3M |
| Research & Development | $50.62M | $46.23M | $52.68M | $48.79M | $40.16M | $49.54M | $44.78M | $55.01M |
| Selling, General & Admin | $203.1M | $208.1M | $185.0M | $169.3M | $150.2M | $130.3M | $120.8M | $113.3M |
| **Operating Income** | -$11.07M | -$49.65M | -$63.36M | -$26.96M | -$46.11M | -$36.71M | -$56.98M | -$72.62M |
| **EBITDA** | -$9.33M | -$47.91M | -$61.67M | -$25.24M | -$44.38M | -$35.01M | -$55.26M | -$70.88M |
| Interest Income | $1.69M | $1.66M | $1.91M | $2.04M | $2.25M | $2.25M | $2.83M | $3.22M |
| Interest Expense | -$3.42M | -$3.20M | $3.09M | -$3.21M | -$3.38M | -$4.09M | $5.26M | -$5.43M |
| Income Before Tax | -$12.79M | -$51.19M | -$64.54M | -$28.13M | -$47.23M | -$48.93M | -$59.41M | -$74.83M |
| Income Tax Expense | $88K | $128K | $0 | $430K | $0 | -$960K | $0 | $85K |
| **Net Income** | -$12.88M | -$51.31M | -$64.54M | -$28.56M | -$47.23M | -$47.97M | -$59.41M | -$74.91M |
| Basic EPS | -$0.25 | -$0.99 | -$1.26 | -- | -$0.94 | -$0.97 | -$1.22 | -- |
| **Diluted EPS** | -$0.25 | -$0.99 | -$1.26 | -- | -$0.94 | -$0.97 | -$1.22 | -- |
| Basic Shares Outstanding | 52.4M | 51.8M | 51.2M | -- | 50.0M | 49.4M | 48.9M | -- |
| Diluted Shares Outstanding | 52.4M | 51.8M | 51.2M | -- | 50.0M | 49.4M | 48.9M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $322.9M | $315.4M | $386.2M | $200.8M | $86.47M | $183.9M | $220.0M | $13.97M | $34.02M | $36.62M |
| **Cash & Short-Term Investments** | $322.9M | $315.4M | $386.2M | $200.8M | $86.47M | $183.9M | $220.0M | $13.97M | $34.02M | $36.62M |
| Accounts Receivable, Net | $224.5M | $142.0M | $94.82M | $37.70M | -- | -- | -- | -- | -- | -- |
| Inventory | $27.94M | $15.73M | $15.13M | $4.32M | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $589.0M | $485.1M | $504.3M | $245.6M | $86.52M | $184.0M | $220.4M | $15.22M | $35.30M | $38.00M |
| Property, Plant & Equipment, Net | $562K | $584K | $846K | $722K | $284K | $53K | $31K | $52K | $68K | $101K |
| Goodwill | $12.04M | $12.04M | $12.04M | $10.31M | -- | -- | -- | -- | -- | -- |
| Intangible Assets | $40.52M | $46.89M | $53.29M | $59.66M | -- | -- | -- | -- | -- | -- |
| Other Non-Current Assets | -- | -- | -- | -- | $323K | $317K | $140K | $112K | $188K | $113K |
| **Total Non-Current Assets** | $100.8M | $83.43M | $83.97M | $85.83M | $1.27M | $2.11M | $170K | $164K | $256K | $214K |
| **Total Assets** | $689.8M | $568.5M | $588.2M | $331.5M | $87.79M | $186.1M | $220.5M | $15.38M | $35.56M | $38.21M |
| Accounts Payable | $65.54M | $72.00M | $40.68M | $38.60M | $13.15M | $13.50M | $10.94M | $3.69M | $3.44M | $4.08M |
| Short-Term Debt | $70.00M | $0 | -- | -- | -- | -- | $2.60M | $3.29M | $3.27M | $269K |
| **Total Current Liabilities** | $378.8M | $230.1M | $138.9M | $96.56M | $23.07M | $23.44M | $24.49M | $10.82M | $12.18M | $7.17M |
| Long-Term Debt | $117.7M | $180.7M | $178.1M | $94.26M | $49.09M | $48.32M | $17.33M | $3.62M | $6.66M | $9.47M |
| **Total Non-Current Liabilities** | $222.7M | $281.4M | $258.4M | $125.4M | $49.09M | $48.90M | $17.33M | $3.62M | $6.66M | $9.47M |
| **Total Liabilities** | $601.5M | $511.5M | $397.3M | $221.9M | $72.15M | $72.34M | $41.83M | $14.44M | $18.84M | $16.64M |
| **Total Debt (incl. Leases)** | $218.2M | $193.0M | $186.4M | $94.68M | $49.71M | $50.12M | $19.93M | $6.91M | $9.93M | $9.74M |
| Common Stock | $5.0K | $5.0K | $5.0K | $4.0K | $3.8K | $3.7K | $3.7K | $3.0K | $2.5K | $1.9K |
| Retained Earnings | -$1.31B | -$1.12B | -$835.6M | -$596.3M | -$409.2M | -$278.8M | -$175.9M | -$107.6M | -$76.58M | -$47.64M |
| **Total Stockholders' Equity** | $88.30M | $57.02M | $191.0M | $109.6M | $15.63M | $113.8M | $178.7M | $938K | $16.72M | $21.57M |
| Total Equity | $88.30M | $57.02M | $191.0M | $109.6M | $15.63M | $113.8M | $178.7M | $938K | $16.72M | $21.57M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $313.9M | $319.9M | $305.1M | $322.9M | $325.3M | $303.0M | $300.9M | $315.4M |
| **Cash & Short-Term Investments** | $313.9M | $319.9M | $305.1M | $322.9M | $325.3M | $303.0M | $300.9M | $315.4M |
| Accounts Receivable, Net | $343.1M | $277.5M | $251.1M | $224.5M | $196.5M | $198.8M | $161.4M | $142.0M |
| Inventory | $42.58M | $37.88M | $31.52M | $27.94M | $23.77M | $18.44M | $16.32M | $15.73M |
| **Total Current Assets** | $724.6M | $656.6M | $611.2M | $589.0M | $565.3M | $536.6M | $494.6M | $485.1M |
| Property, Plant & Equipment, Net | $943K | $874K | $567K | $562K | $605K | $667K | $773K | $584K |
| Goodwill | $12.04M | $12.04M | $12.04M | $12.04M | $12.04M | $12.04M | $12.04M | $12.04M |
| Intangible Assets | $35.75M | $37.36M | $38.95M | $40.52M | $42.13M | $43.73M | $45.32M | $46.89M |
| **Total Non-Current Assets** | $102.1M | $104.9M | $102.4M | $100.8M | $103.9M | $103.2M | $102.0M | $83.43M |
| **Total Assets** | $826.8M | $761.4M | $713.6M | $689.8M | $669.2M | $639.8M | $596.7M | $568.5M |
| Accounts Payable | $96.08M | $78.97M | $106.7M | $65.54M | $54.23M | $91.63M | $85.66M | $72.00M |
| Short-Term Debt | $70.00M | $70.00M | $70.00M | $70.00M | $70.00M | $70.00M | -- | $0 |
| **Total Current Liabilities** | $509.7M | $460.4M | $439.2M | $378.8M | $360.3M | $342.1M | $243.9M | $230.1M |
| Long-Term Debt | $118.1M | $118.0M | $117.8M | $117.7M | $117.6M | $117.5M | $181.4M | $180.7M |
| **Total Non-Current Liabilities** | $211.6M | $217.7M | $219.8M | $222.7M | $235.2M | $224.6M | $299.6M | $281.4M |
| **Total Liabilities** | $721.3M | $678.1M | $659.0M | $601.5M | $595.5M | $566.7M | $543.5M | $511.5M |
| **Total Debt (incl. Leases)** | $224.2M | $224.7M | $219.9M | $218.2M | $218.6M | $217.3M | $211.2M | $193.0M |
| Common Stock | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K |
| Retained Earnings | -$1.43B | -$1.42B | -$1.37B | -$1.31B | -$1.28B | -$1.23B | -$1.18B | -$1.12B |
| **Total Stockholders' Equity** | $105.4M | $83.30M | $54.59M | $88.30M | $73.73M | $73.08M | $53.20M | $57.02M |
| Total Equity | $105.4M | $83.30M | $54.59M | $88.30M | $73.73M | $73.08M | $53.20M | $57.02M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$183.2M | -$287.2M | -$239.2M | -$187.1M | -$130.4M | -$102.9M | -$68.35M | -$30.97M | -$28.94M | -$27.20M |
| Depreciation & Amortization | $6.88M | $6.92M | $6.83M | $4.40M | $76K | $24K | $37K | $49K | $43K | $20K |
| Stock-Based Compensation | $93.75M | $85.22M | $62.62M | $37.73M | $20.80M | $14.76M | $6.12M | $1.75M | $2.07M | $2.03M |
| Change in Receivables | -$82.46M | -$47.18M | -$57.12M | -$37.70M | -- | -- | -- | -- | -- | -- |
| Change in Inventory | -$10.66M | $744K | -$8.16M | -$1.33M | -- | -- | -- | -- | -- | -- |
| Change in Payables | -$6.46M | $31.32M | $2.07M | $25.46M | -$355K | $2.56M | $7.26M | $252K | -$646K | $2.19M |
| **Operating Cash Flow** | -$93.41M | -$128.4M | -$145.1M | -$116.5M | -$108.2M | -$78.46M | -$46.38M | -$30.05M | -$26.47M | -$21.28M |
| Capital Expenditure | -$480K | -$270K | -$582K | -$702K | -$308K | -$46K | -$16K | -$33K | -$9.9K | -$105K |
| **Free Cash Flow** | -$93.89M | -$128.7M | -$145.7M | -$117.2M | -$108.5M | -$78.50M | -$46.39M | -$30.09M | -$26.48M | -$21.39M |
| **Investing Cash Flow** | -$480K | -$270K | -$582K | -$53.70M | -$308K | -$46K | -$16K | -$33K | -$9.9K | -$105K |
| Common Stock Issued | $67.90M | $40.78M | $258.8M | $243.8M | $7.44M | $14.13M | $238.2M | $12.88M | $23.68M | -- |
| **Financing Cash Flow** | $101.5M | $57.84M | $331.0M | $284.6M | $11.13M | $42.41M | $252.4M | $10.03M | $23.88M | $9.97M |
| **Net Change in Cash** | $7.58M | -$70.84M | $185.4M | $114.4M | -$97.40M | -$36.09M | $206.0M | -$20.05M | -$2.60M | -$11.42M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$12.88M | -$51.31M | -$64.54M | -$28.56M | -$47.23M | -$47.97M | -$59.41M | -$74.91M |
| Depreciation & Amortization | $1.74M | $1.73M | $1.69M | $1.72M | $1.73M | $1.71M | $1.72M | $1.74M |
| Stock-Based Compensation | $26.36M | $27.15M | $23.44M | $22.73M | $23.10M | $24.61M | $23.31M | $21.99M |
| Change in Receivables | -$65.66M | -$26.40M | -$26.60M | -$27.96M | $2.32M | -$37.43M | -$19.40M | -$17.91M |
| Change in Inventory | -$4.26M | -$5.89M | -$3.11M | -$3.64M | -$4.99M | -$1.78M | -$249K | -$1.13M |
| Change in Payables | $17.11M | -$27.73M | $41.16M | $11.31M | -$37.40M | $5.97M | $13.66M | $7.74M |
| **Operating Cash Flow** | -$9.47M | -$32.95M | -$20.70M | -$18.65M | $1.05M | -$32.42M | -$43.38M | -$26.20M |
| Capital Expenditure | -$197K | -$450K | -$121K | -$71K | -$58K | -$13K | -$338K | -$30K |
| **Free Cash Flow** | -$9.67M | -$33.40M | -$20.82M | -$18.72M | $988K | -$32.44M | -$43.71M | -$26.23M |
| **Investing Cash Flow** | -$197K | -$450K | -$121K | -$71K | -$58K | -$13K | -$338K | -$30K |
| Common Stock Issued | $0 | $13.47M | $6.34M | $5.67M | $9.95M | $32.63M | $19.65M | -- |
| **Financing Cash Flow** | $3.67M | $48.15M | $2.99M | $16.39M | $21.27M | $34.54M | $29.27M | $14.24M |
| **Net Change in Cash** | -$5.99M | $14.74M | -$17.83M | -$2.34M | $22.26M | $2.11M | -$14.44M | -$11.99M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 92.6% | 91.4% | 90.4% | -- | -- | -- | -- | -- | -- | -- |
| **Operating Margin** | -26.1% | -72.7% | -85.7% | -- | -- | -- | -- | -- | -- | -- |
| **Net Profit Margin** | -28.7% | -74.5% | -88.4% | -- | -- | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -207.5% | -503.8% | -125.3% | -170.8% | -834.3% | -90.4% | -38.2% | -3301.5% | -173.1% | -126.1% |
| Return on Assets (ROA) | -26.6% | -50.5% | -40.7% | -56.5% | -148.5% | -55.3% | -31.0% | -201.3% | -81.4% | -71.2% |
| Current Ratio | 1.55x | 2.11x | 3.63x | 2.54x | 3.75x | 7.85x | 9.00x | 1.41x | 2.90x | 5.30x |
| Quick Ratio | 1.48x | 2.04x | 3.52x | 2.50x | 3.75x | 7.85x | 8.98x | 1.29x | 2.79x | 5.11x |
| Debt to Equity | 2.47x | 3.38x | 0.98x | 0.86x | 3.18x | 0.44x | 0.11x | 7.37x | 0.59x | 0.45x |
| **Revenue Growth (YoY)** | +65.5% | +42.5% | -- | -- | -- | -- | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | +67.7% | +44.1% | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 93.2% | 93.2% | 92.6% | 92.6% | 91.9% | 91.5% | 91.5% | 91.4% |
| **Operating Margin** | -17.5% | -24.0% | -24.4% | -26.1% | -37.8% | -46.2% | -62.5% | -72.7% |
| **Net Profit Margin** | -18.2% | -24.7% | -26.6% | -28.7% | -40.9% | -49.9% | -64.4% | -74.5% |
| Return on Equity (ROE) | -149.2% | -230.1% | -345.0% | -207.5% | -311.3% | -337.9% | -523.0% | -503.8% |
| Return on Assets (ROA) | -19.0% | -25.2% | -26.4% | -26.6% | -34.3% | -38.6% | -46.6% | -50.5% |
| Current Ratio | 1.42x | 1.43x | 1.39x | 1.55x | 1.57x | 1.57x | 2.03x | 2.11x |
| Quick Ratio | 1.34x | 1.34x | 1.32x | 1.48x | 1.50x | 1.51x | 1.96x | 2.04x |
| Debt to Equity | 2.13x | 2.70x | 4.03x | 2.47x | 2.96x | 2.97x | 3.97x | 3.38x |
| **Revenue Growth (YoY)** | +51.9% | +45.5% | +57.4% | +65.0% | +63.2% | +72.1% | +62.0% | +66.0% |
| Gross Profit Growth (YoY) | +52.1% | +49.9% | +58.0% | +69.7% | +65.1% | +72.7% | +62.5% | +68.7% |
| Operating Cash Flow Growth (YoY) | -1005.3% | -- | -- | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -1078.3% | -- | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
